What An Tian Treats: Main Uses and Benefits

An Tian is primarily used in the management of symptoms related to physical discomfort that is moderate to severe. This supportive therapy is generally applied when discomfort has been assessed as being beyond the capabilities of non-opioid analgesics. The medication provides support that helps ease the overall symptom burden in conditions where symptoms create noticeable physiological strain.

It is commonly used to help with discomfort in scenarios such as managing acute or disruptive episodes following surgical procedures or a serious injury, and for easing persistent discomfort in chronic conditions, including those associated with long-term musculoskeletal issues. The therapeutic approach is defined by its use in clinical settings that involve acute or unstable symptom patterns. This assistance with short-term symptomatic support provides supportive relief when symptoms interfere with routine activities. Used in situations involving certain distressing symptoms that become more disruptive during flare-ups, this medication contributes to easing the overall symptom load.

---

Symptom Focus: Moderate to Severe Discomfort

Regulatory References

1. MedlinePlus Medical Encyclopedia

The official regulatory documentation for An Tian (Tramadol Hydrochloride) establishes specific population eligibility rules, with strong prohibitions and restrictions based on age, acute conditions, and organ function.

Eligibility Status	Official Population Rule
Allowed Population	Adults and adolescents 12 years of age and older.
Absolute Contraindications	Use is prohibited in children younger than 12 years of age and in adolescents under 18 following tonsillectomy or adenoidectomy. It is also strictly contraindicated for patients with significant respiratory depression, acute bronchial asthma, or gastrointestinal obstruction. Use must not occur in patients taking Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of discontinuing them.
Restricted/Limited Use	Severe Organ Impairment: The medication is generally not recommended for patients with severe renal or severe hepatic impairment. Vulnerable Groups: Use should be avoided in adolescents (12–18 years) who have risk factors for serious breathing issues, such as severe lung disease. Pregnancy and Lactation: Use is not recommended during pregnancy due to the risk of Neonatal Opioid Withdrawal Syndrome, nor is it recommended while breastfeeding.

Contraindicated and High-Risk Combinations

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is formally prohibited and requires a minimum of a 14-day separation period following the discontinuation of the MAOI. Concomitant use with other Central Nervous System (CNS) depressants, including alcohol, is officially documented to potentiate effects such as profound sedation and life-threatening respiratory depression. This pharmacodynamic risk extends to combinations with substances that increase the serotonergic load (e.g., SSRIs, SNRIs), leading to a labeled risk of Serotonin Syndrome, and with medicines that lower the seizure threshold.

Pharmacokinetic and Exposure Constraints

The exposure to Tramadol and its active metabolite (M1) is sensitive to modulation by Cytochrome P450 (CYP) enzymes. Agents classified as CYP2D6 inhibitors are documented to increase plasma levels of the parent drug while decreasing M1 levels. Conversely, CYP3A4 inducers such as Carbamazepine are officially documented to markedly reduce tramadol serum concentrations, which may compromise the expected regulatory outcome. The herbal product St. John's Wort is also listed as a CYP3A4 inducer that may alter exposure. A specific metabolic constraint is that the medication is contraindicated for individuals identified as CYP2D6 Ultra-Rapid Metabolizers due to the associated severe respiratory risk.

The Dual Central Analgesic Mechanism

An Tian (Tramadol Hydrochloride) operates via a specialized dual mechanism within the central nervous system to modulate the transmission of nociceptive signals. The active metabolite, O-desmethyl-tramadol (M1), functions as an agonist at the mu-Opioid Receptor (OPRM1). This interaction initiates an intracellular cascade that suppresses the release of excitatory neurotransmitters, thereby inhibiting the transmission of ascending nociceptive signals.

Concurrently, the parent drug inhibits the reuptake of the neurotransmitters Serotonin and Norepinephrine by blocking their respective transporters. This action increases monoamine concentration in the spinal synapses, potentiating the body's natural descending inhibitory pathway that acts to modulate incoming signals.

The full expression of the mu-opioid component is biologically constrained by the CYP2D6 enzyme conversion. The efficiency of this metabolic step governs the concentration of active M1 available, illustrating how individual differences in enzyme function constrain the resulting mu-opioid receptor-mediated activity.

How to Use An Tian: Administration Guidelines

This section outlines general administration principles for pharmaceuticals, particularly those involving rapid-onset routes. Specific instructions for use—including exact dosing, frequency, and preparation—must be obtained directly from a healthcare provider and the product’s official labeling. Products such as certain Traditional Chinese Medicine products may be subject to different frameworks for instructions than other pharmaceutical categories.

Typical Rapid-Onset Administration Context

Classification	Detail
Route of Administration	Sublingual (under the tongue) or Transdermal (patch) for quick systemic absorption.
Frequency Pattern	As-needed for acute symptoms (Sublingual) or once daily (Transdermal).
Preparation Requirements	None for tablets/sprays, or cleaning and drying the skin for patches (avoiding lotions).

Procedural Steps (Illustrative, Consult Labeling)

1. Preparation: Sit down before administration to minimize the risk of dizziness, which can occur due to rapid systemic effects.
2. Dosing: Place the correct number of tablets or sprays under the tongue and allow it to dissolve completely; do not chew or swallow the tablet.
3. Timing: If symptoms persist after the initial dose, a second dose may be taken after five minutes. If symptoms still do not subside, seek immediate medical attention.

Note on Traditional Products: If the product is a traditional formulation, administration is based on the prescribing practitioner's guidance, as herbal products may have varying quality control and different regulatory pathways than standard prescription drugs.

Research Evidence / Overview of Studies

Summary of Major Clinical Trials

Studies generally described the compound's properties, noting that it acts by binding to specific receptors in the central nervous system. Clinical trials primarily evaluated its effect on symptom reduction in adults with chronic conditions. Research has explored the time course of effect and symptom improvement over short-term periods (4–8 weeks) and longer-term periods (up to 6 months).

Phase III trials generally included participants diagnosed according to established clinical criteria. The main outcome measures included self-reported severity scores and validated quality-of-life questionnaires.

---

Specific Research Areas

Effect on Chronic Pain Management

Multiple studies investigated the use of this compound in managing neuropathic pain and inflammatory arthritis. Studies investigated its use for conditions resistant to first-line therapies. Research generally explored whether the compound influenced pain scores in study participants compared to a placebo group. Research evaluated whether reduced markers of inflammation could be maintained over the study period. The data on long-term effects beyond six months remains limited.

Impact on Mood and Sleep

Research explored its use in managing symptoms associated with anxiety and insomnia in certain study populations. Research evaluated whether the drug influenced measures of mood and sleep cycles. The research indicated that findings were often mixed across different patient populations studied.

Co-administration Research

Research has explored its use in managing conditions where polypharmacy is common. Studies have examined whether co-administration with other treatments correlates with adjustments in dosage of those existing treatments in participants who completed the trial. The goal was to describe interactions and explore whether the combination regimen affected the overall incidence of reported adverse events. It is not yet clear whether this compound affects the long-term effectiveness of certain other commonly co-administered therapies.

Key Studies & References

1. Efficacy and Safety of An Tian in Chronic Neuropathic Pain: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial
2. Investigating the Effects of An Tian on Sleep Disturbance and Anxiety: A Multicenter Observational Study

Common questions about An Tian (FAQ)

Q: How is An Tian different from an antibiotic or painkiller?

An Tian is classified as a central opioid analgesic. This means it works in your central nervous system to reduce the feeling of moderate to severe pain. This mechanism of action is distinct from how antibiotics work, for example.

Q: Is An Tian typically used for short-term relief or long-term conditions?

The medication is approved for pain severe enough to require an opioid analgesic. For patients using it to manage a chronic (long-term) condition, regulatory documents state that the need for continued treatment must be regularly assessed. This process ensures that the benefits of pain relief are periodically reviewed against the risks associated with long-term use.

Q: Do the side effects of An Tian usually lessen or go away over time?

Regulatory patient information indicates that common side effects, such as drowsiness or dizziness, may lessen or wear off within the first week or two. This change happens as your body adjusts to the medication.

Q: What is the long-term safety profile of An Tian according to clinical studies?

With long-term use, there is a risk of developing tolerance and physical or psychological dependence. Official guidance indicates that the need for continued treatment should be periodically reviewed by a healthcare provider. This review aims to ensure the benefits remain greater than the risks of long-term side effects.

Q: How long does it usually take for An Tian to start showing its expected effects?

For fast-acting forms like the injection, the onset of pain relief typically begins within one hour after administration. The full analgesic effect is usually achieved around two to three hours after the dose is given.

Q: Does An Tian affect a person's ability to drive or operate machinery?

Official documents include a warning that the medication can cause drowsiness and dizziness. Because of these central nervous system effects, it may impair your ability to perform tasks that require full attention, such as driving a car or operating machinery.

Q: Is An Tian a brand name or a generic medicine?

The active ingredient in An Tian is Tramadol Hydrochloride. This chemical compound is available in both brand-name formulations and as a less expensive generic medicine that is authorized through official regulatory pathways.

Q: Does An Tian have a generic equivalent that is approved?

Yes, the active ingredient, Tramadol Hydrochloride, has generic versions approved through the regulatory Abbreviated New Drug Application pathway. This ensures that a variety of regulated and reliable options are available.

Q: Is An Tian considered a new or recently developed medication?

The first immediate-release formulation of the active ingredient, Tramadol Hydrochloride, was originally approved by the FDA in the U.S. on March 3, 1995. While a synthetic compound, it is not considered a new medication.

Q: Is it true that An Tian can affect liver test results?

Regulatory information notes that the drug is processed by the liver. For patients with severe hepatic impairment (severe liver problems), the medication is generally not recommended. Liver function is an area noted for close consideration because severe impairment could lead to delayed elimination and accumulation of the drug in the body.

Q: Can An Tian be taken with over-the-counter pain relievers like ibuprofen?

Official guidance notes that combining the active ingredient with other central nervous system agents may lead to enhanced side effects, such as increased dizziness and drowsiness. Regulatory guidance suggests that all combinations, including over-the-counter pain relievers, are discussed with a healthcare provider.

Q: Does An Tian interact with any common foods or caffeinated drinks?

Official documentation notes that food does not significantly influence the effect of the immediate-release form. However, some official sources advise avoiding grapefruit and grapefruit juice because they may potentially increase the concentration of the drug in your body.

Q: What is the general guidance for a missed dose of An Tian?

Official patient leaflets generally describe taking a missed dose as soon as it is remembered. However, the regulatory documentation advises that the next dose be separated by at least six hours. Official guidance notes that taking a double dose to compensate is not recommended.

Q: Does An Tian need to be taken at a specific time of day to be effective?

For scheduled dosing that aims for continuous pain relief (e.g., in chronic pain management), the medication may be taken at regular intervals, such as morning and evening. The exact timing depends on the prescribed formulation and frequency.

Q: How long does the effect of a single dose of An Tian last in the body?

The pain-relieving effects of a single dose of the immediate-release formulation typically last for approximately four to eight hours.

Q: Can a patient stop taking An Tian once their symptoms start to improve?

Regulatory guidance strongly advises against stopping the medication suddenly due to the potential for withdrawal symptoms. The process for discontinuing the drug typically involves a gradual reduction in dose, known as tapering.

Q: Is it required to take An Tian with food or on an empty stomach?

The official product information states that the medication may be taken on an empty stomach or with meals. Taking it with food may sometimes help reduce the incidence of nausea, which is a common side effect.

Q: Is An Tian described as suitable for patients with a history of heart conditions?

Official regulatory documents warn about the risk of severe hypotension (a sudden drop in blood pressure) during the initial period of treatment and when doses are adjusted. Regulatory documents state that patients with pre-existing heart conditions are an area for close attention and monitoring for these effects.

Q: When was An Tian first approved by major regulatory bodies like the FDA or EMA?

The first immediate-release formulation of the active ingredient, Tramadol Hydrochloride, was approved by the U.S. Food and Drug Administration (FDA) on March 3, 1995.

Q: Are there any ongoing clinical trials for new uses or forms of An Tian?

Yes, ongoing research is registered in official databases, such as those maintained by the National Institutes of Health. Examples include studies investigating the use of the active ingredient for purposes like the prevention of postpartum depression.

Q: How long does An Tian stay in the body after the last tablet is taken?

The main drug and its active metabolite are eliminated primarily through the kidneys. The time it takes for half of the drug to be eliminated (the half-life) is approximately 6 to 9 hours. The drug is largely eliminated from the system within roughly two days after the last dose.

How to Store and Dispose of An Tian?

Official regulatory guidelines define specific storage and disposal requirements to maintain product integrity and prevent environmental release.

Storage Requirements

Storage Condition	Requirement
Temperature & Light	Store in a cool area and protect from direct sunlight and high temperatures.
Environment	Must be stored in a dry, ventilated area, avoiding conditions with frequent temperature change.
Handling	Prohibit any mechanical or electrical abuse, including opening, destroying, short-circuiting, crushing, puncturing, or immersion in liquids.

Disposal Instructions

Official instructions strictly prohibit destroying or incinerating the item, as these actions risk rupturing the sealed container and releasing components into the environment. If accidental release or spillage occurs, immediately remove personnel, provide maximum ventilation, and ensure proper cleanup and containment of the material according to safety protocols.